Publicité
Publicité

KZIA

KZIA logo

Kazia Therapeutics Limited - ADR

6.80
USD
Sponsorisé
+0.02
+0.24%
09 janv., 15:59 UTC -5
Fermé
exchange

Après-marché

6.78

-0.02
-0.24%

KZIA Rapports sur les bénéfices

Ratio de surprise positive

KZIA a dépassé 2 des 5 dernières estimations.

40%

Prochain rapport

Date du prochain rapport
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Variation implicite de Q4 25 (Revenue/ EPS)
--
/
--
Variation implicite de Q-- -1 (Revenue/ EPS)
--
/
--

Kazia Therapeutics Limited - ADR earnings per share and revenue

On 07 nov. 2025, KZIA reported earnings of 1.42 USD per share (EPS) for Q4 25, beating the estimate of -1.32 USD, resulting in a 207.09% surprise. Revenue reached 42.00 mille, compared to an expected 8.16 mille, with a 414.71% difference. The market reacted with a +0.82% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analystes forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
FAQ
For Q4 2025, Kazia Therapeutics Limited - ADR reported EPS of $1.42, beating estimates by 207.09%, and revenue of $42.00K, 414.71% above expectations.
The stock price moved up 0.82%, changed from $7.33 before the earnings release to $7.39 the day after.
The next earning report is scheduled for --.
Based on -- analystes, Kazia Therapeutics Limited - ADR is expected to report EPS of -- and revenue of -- for Q-- --.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité